Back
DBS Group Holdings Vs. Akero Therapeutics Industry Stock Comparison
Buy
70
DBSDY
DBS Group Holdings
Last Price:
$133.75
Seasonality Move:
2.76%
Buy
69
AKRO
Akero Therapeutics
Last Price:
$49.93
Seasonality Move:
-13.61%
Buy
70
DBS Group Holdings (DBSDY)
is a Buy
Is DBS Group Holdings a Buy, Sell or Hold?
-
The current DBS Group Holdings [DBSDY] share price is $133.75. The Score for DBSDY is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
DBSDY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $49.95. The Score for AKRO is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DBSDY Stock Price Chart
What is DBS Group Holdings's stock price today?
-
The DBS Group Holdings share price today is $133.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DBSDY is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $49.95The current trend is moderately bullish and AKRO is experiencing slight selling pressure.
DBSDY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.23 | Buy |
Relative Strength Index (14 RSI): | 66.95 | Buy |
Chaikin Money Flow: | 72538 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.24 - 131.84) | Buy |
Bollinger Bands (100): | (119.93 - 130.33) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.76 | Buy |
Relative Strength Index (14 RSI): | 64.15 | Buy |
Chaikin Money Flow: | -84584 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.24 - 53.26) | Buy |
Bollinger Bands (100): | (23.77 - 40.49) | Buy |
DBSDY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 131.91 | Buy |
20-day SMA: | 130.15 | Buy |
50-day SMA: | 129.31 | Buy |
200-day SMA: | 116.31 | Buy |
8-day EMA: | 132.16 | Buy |
20-day EMA: | 130.79 | Buy |
50-day EMA: | 128.67 | Buy |
200-day EMA: | 117.31 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.02 | Sell |
20-day SMA: | 42.05 | Buy |
50-day SMA: | 34.2 | Buy |
200-day SMA: | 27.85 | Buy |
8-day EMA: | 51.73 | Sell |
20-day EMA: | 45.31 | Buy |
50-day EMA: | 37.61 | Buy |
200-day EMA: | 30.47 | Buy |
DBS Group Holdings Earnings Growth & DBSDY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.
DBS Group Holdings Technical Analysis
Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |